LC
AMGN icon

Lavaca Capital’s Amgen AMGN Stock Holding History

Lavaca Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$558 – 273
2025
Q2 		$558 Hold
2
– – ﹤0.01% 262
2025
Q1 		$623 Sell
2
-123
-98% -$36.3K ﹤0.01% 243
2024
Q4 		$32.6K Buy
+125
New +$37.1K 0.01% 217
2021
Q2 		– Sell
-3,500
Closed -$871K – 150
2021
Q1 		$871K Buy
3,500
+1,852
+112% +$442K 0.07% 70
2020
Q4 		$379K Buy
1,648
+748
+83% +$172K 0.05% 81
2020
Q3 		$229K Buy
+900
New +$223K 0.04% 98
2019
Q2 		– Sell
-400
Closed -$76K – 105
2019
Q1 		$76K Hold
400
– – 0.06% 129
2018
Q4 		$78K Buy
+400
New +$78K 0.08% 106

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lavaca Capital's AMGN Position: Q3 2025 in Review

Lavaca Capital sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2 shares — an estimated $558 sold.

Lavaca Capital first reported a position in AMGN in Q4 2018 and held it in 8 quarters. The position peaked at $871K in Q1 2021. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Lavaca Capital reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Lavaca Capital sold 2 Amgen shares in Q3 2025, an estimated $558.
  • Lavaca Capital first reported a position in Amgen in Q4 2018 and held it in 8 quarters.
  • Lavaca Capital's Amgen position peaked at $871K in Q1 2021.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Lavaca Capital's 13F filing for Q3 2025, filed 13 Nov 2025.